| 000 | 01665 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250518080039.0 | ||
| 264 | 0 | _c20201019 | |
| 008 | 202010s 0 0 eng d | ||
| 022 | _a1471-244X | ||
| 024 | 7 |
_a10.1186/s12888-019-2418-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKern, David M | |
| 245 | 0 | 0 |
_aTreatment patterns and sequences of pharmacotherapy for patients diagnosed with depression in the United States: 2014 through 2019. _h[electronic resource] |
| 260 |
_bBMC psychiatry _c01 2020 |
||
| 300 |
_a4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntidepressive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntidepressive Agents, Tricyclic _xtherapeutic use |
| 650 | 0 | 4 |
_aDepression _xdiagnosis |
| 650 | 0 | 4 | _aDrug Prescriptions |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypnotics and Sedatives _xtherapeutic use |
| 650 | 0 | 4 |
_aInsurance Claim Reporting _xtrends |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aSelective Serotonin Reuptake Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aSerotonin and Noradrenaline Reuptake Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aUnited States _xepidemiology |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aCepeda, M Soledad | |
| 700 | 1 | _aDefalco, Frank | |
| 700 | 1 | _aEtropolski, Mila | |
| 773 | 0 |
_tBMC psychiatry _gvol. 20 _gno. 1 _gp. 4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12888-019-2418-7 _zAvailable from publisher's website |
| 999 |
_c30482095 _d30482095 |
||